After 20 years in the retail and consumer goods sector, I became a research analyst and market strategist for Capital Ladder Advisory Group. Since 2011, I have published some 400+ articles surrounding mainstream retailers like Bed Bath & Beyond, Target, Costco and more. I've covered consumer goods corporations such as Apple, Keurig Green Mountain, SodaStream, Skullcandy, Fitbit and more. To date, I've garnered over a hundred media references to my analytics including Forbes. Presently, I am a contracted consultant to many retail and consumer goods companies in North America and manufacturing entities in China and Korea.

Growth Vs. Vaccine

The J.P. Morgan View Growth versus virus now, vaccine versus virus later —an update on a conflict and a hope Cross-asset strategy: The dominant macro narrative of the past several weeks hasn’t changed much, and neither has the pattern of uneven advances across and within global markets. The reality of a booming economy versus the…...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

End of the Rally? Monday Must Knows

Welcome to another trading week!! In appreciation of all of our Basic Membership level participants and daily readers of finomgroup.com content, we offer the following excerpts from our Weekly Research Report. Our weekly Report is extremely detailed and has proven to help guide investors and traders during all types of market conditions with thoughtful insights and analysis, graphs,…

History of Markets Is On Full Display and Trending…

The S&P 500 (SPX) flip flopped this week, but spent the last few days hovering around a 40-point range. The index closed Friday down just 0.19% YTD and is 4.77% below its record close set just 5 months ago. The benchmark index was up 1.25% for the week, while achieving a new bear-to-new bull market…...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Weekly State of the Markets: 7/16/2020

Welcome to this week’s State of the Markets with Wayne Nelson and Seth Golden. Please click the following link to review the SOTM video. In this week’s episode, we discuss the Nasdaq’s recent outperformance and general trend with overbought conditions and forward looking probabilities. On the horizon, risks to the market remain centered on fiscal policy needs to sustain the economic recovery. Much…...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Bill Miller 2Q 2020 Market Letter

For a long time, I used to read Reminiscences of a Stock Operator almost every year. I don’t do that anymore, not because I find its lessons dated, but because I had it almost memorized so could direct my attentions elsewhere. The market’s behavior since the March 23rd bottom of 2191 to the 43% gain by July…

Monday Must Knows: In Sideways Markets

Welcome to another trading week!! In appreciation of all of our Basic Membership level participants and daily readers of finomgroup.com content, we offer the following excerpts from our Weekly Research Report. Our weekly Report is extremely detailed and has proven to help guide investors and traders during all types of market conditions with thoughtful insights and analysis, graphs,…

Uncertainty Is Only Temporary For Markets

This past trading week, the markets continued to look beyond the rising COVID-19 infection rate and toward a future economic and societal recovery. The S&P 500 (SPX) made a concerted effort to finish the trading week on a high note, which it succeeded in doing. The benchmark index rose 1.76% for the week and finished…...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Weekly State of the Market: 7/10/2020

Welcome to this week’s State of the Markets with Wayne Nelson and Seth Golden. Please click the following link to review the SOTM video. In this week’s episode, we discuss the consistent 2009 adherence of the 2020 market recovery. Additionally, we take a look at some of the election cycle implications for investors as the incumbent is finding approval ratings fall under the…...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Morgan Stanley Biotechnology Team: Year-End Vaccine Probable

Biotechnology | North America COVID-19: Increasing ConvictionMultiple Vaccine Candidates WillHave Pivotal Data Before YE20 While a pre-election result is possible, we see early-to-mid November as our base case for PhIII data. Pfizer/BioNTech and Moderna appear slightly ahead of AstraZeneca for US PhIII data, though we note many details on the PhIIIs have not been disclosed…...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here